AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Colette Kress helped bring Israel to the heart of Nvidia's AI business. Now she's in charge.
2
“The next Palo Alto Networks has already been born, and it is probably in Tel Aviv”
3
Qualcomm's "performance-focused" layoffs reach India, but employees describe a broader restructuring
4
Amdocs' four-year restructuring drive has cost $436 million and cut around 7,500 jobs
5
The race to replace Jensen Huang: Nvidia's potential successors include an Israeli executive
More news

Weight Loss

4 stories about Weight Loss
גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
גלולה של חברת אפיטומי epitomee

Weight loss pill success sparks stock surge at Epitomee Medical

04.09.23|Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
מוסף תרופה תרופות בית מרקחת

Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns

16.02.20|Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%